NATCO PHARMA
Back to Income Statement
|
NATCO PHARMA Last 5 Year Appropriations History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Appropriations | ₹6,351 Cr | ₹4,681 Cr | ₹3,382 Cr | ₹2,738 Cr | ₹2,680 Cr |
What is the latest Appropriations of NATCO PHARMA ?
| Year | Appropriations |
|---|---|
| Mar2025 | ₹6,351 Cr |
| Mar2024 | ₹4,681 Cr |
| Mar2023 | ₹3,382 Cr |
| Mar2022 | ₹2,738 Cr |
| Mar2021 | ₹2,680 Cr |
How is Appropriations of NATCO PHARMA Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2025 | ₹6,351 Cr | 35.69 | |
| Mar2024 | ₹4,681 Cr | 38.40 | |
| Mar2023 | ₹3,382 Cr | 23.51 | |
| Mar2022 | ₹2,738 Cr | 2.17 | |
| Mar2021 | ₹2,680 Cr | - | |
Compare Appropriations of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹16,457.5 Cr | -9.6% | -18.3% | 4.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,926.0 Cr | -1.2% | -2.3% | 5.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,062.0 Cr | -1% | -0.9% | -0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,806.0 Cr | -1.3% | 1.4% | 38.1% | Stock Analytics | |
| CIPLA | ₹112,910.0 Cr | -0.1% | 4.8% | -6.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,755.0 Cr | -2.8% | -0.3% | 1.2% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -9.6% |
-18.3% |
4.8% |
| SENSEX | -2% |
-3.8% |
-8.6% |
You may also like the below Video Courses